Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$15,051,648
+$14,183,386 QoQ
Shares Held
12,549
+1229.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#1,036
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Applied Finance Capital Management, LLC holds $53,647,387 across 10 Drug Manufacturers - General names. LLY ranks #2 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
133,454 | $17,148,839 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
12,549 | $15,051,648 | |
| 3 | JNJ |
Johnson & Johnson
|
25,604 | $6,502,647 | |
| 4 | ABBV |
AbbVie Inc.
|
25,128 | $6,323,209 | |
| 5 | AMGN |
Amgen Inc
|
6,845 | $2,478,711 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,950 | $2,071,439 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
14,693 | $1,856,313 | |
| 8 | NVS |
Novartis AG
|
6,260 | $981,067 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,051,648 | 12,549 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $868,262 | 944 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,209,015 | 1,125 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $879,739 | 1,153 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $820,845 | 1,053 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $870,509 | 1,054 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $660,060 | 855 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $746,847 | 843 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $597,550 | 660 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $402,205 | 517 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $301,369 | 517 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $379,213 | 706 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $371,432 | 792 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $259,968 | 757 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $246,942 | 675 | Shares | Sole | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||